Victoza Injuries: Cancer of the Pancreas

VICTOZA INJURIES : CANCER OF THE PANCREAS Victoza (liraglutide) is a drug used to control blood sugar levels in 2009: An FDA Committee 2011: The FDA type-2 diabetes patients. It is administered through a once-daily injection found that cancer of the warned that Victoza is that works by increasing insulin while making the stomach feel full. In pancreas is a serious concern not recommended as January 2010, the FDA approved Victoza for sale on the market by its associated with Victoza. the first choice for manufacturer, Novo Nordisk. The drug made over $2.3 billion in sales in treating diabetes. it's first year on the market and in 2012 it had over $9.4 million in sales. 2010: The FDA approved Victoza Serious Side Effects: even though panel Pancreatitis members had 2012: The FDA received Kidney/Renal Failure concerns about over 9,000 adverse event 13% Tumors its safety. reports from Victoza patients. Cancer of the Pancreas of Patients taking Victoza Experience Common Side Effects: Headache Nausea Pain Nausea Diarrhea Swelling Victoza's medication guide stated that, "Because of the uncertain Pancreatitis: It has been alleged that Kidney/Renal Failure: Tumors and Cancer: (Including relevance of the rodent thyroid C-cell tumor findings to humans, prescribe Victoza patients are 4 times more likely Victoza's label warns that breast cancer, prostate cancer, to suffer pancreatitis than patients thyroid cancer) According to a 2009 FDA Committee Report, Victoza only to patients for whom the potential benefits are considered to kidney/renal impairment taking other diabetes medicines. In the months following the drug's approval outweigh the potential risk." have been reported in some cases. clinical trials found 29 cases of Call d'Oliveira e Associates there were 200 reports of pancreatitis growths and tumors, including 5 and by 2012 the number of these cases of prostate cancer and 5 at 1-800-992-6878 for a free consultation reports totalled 635. cases of thyroid cancer. DA